Categories: world

Stent: It's official, Indian-made stents as good as the best | India News

Following a major controversy about the quality of stents manufactured in India, yet another study comparing an Indian stent with…

Following a major controversy about the quality of stents manufactured in India, yet another study comparing an Indian stent with the main foreign stent brand has shown that it is equally good. On Monday, the results showed a 10-year study comparing clinical results by the Indian stent Yukon Choice PC with market leader Xience stents from the US company Abbott that they were equally good. A study that was presented two months back had also revealed that another Indian stent, Supra Flex, was as good as Xience.


At the Scientific Session of the American Heart Association in Chicago, cardiologists from Germany presented the results of a prolonged follow-up of 2,603 ​​patients randomized to treatment with two new generation genes &#821

1; everolimus eluting Xience and sirolimus eluting Yukon Choice – and a first-generation sirolimus that elutes Cypher stent. Cypher is not on the market anymore. The study published in AHA’s journal showed that there was no difference in the outcome between the two new generation stents.

In February 2017, the government had reduced the price of stents
which results in a three-thirds reduction in the prices of drugs that elute stents. Several multinational stent companies had threatened to withdraw their stents from India, claiming they were superior to Indian and thus deserved a higher price. Several cardiologists also questioned the quality of Indian stents. But with studies showing that Indian stents are as good as foreign, cardiologists seem to have changed thanks.

“This is the type of study we need – large, randomized, long-term studies. More Indian companies should do such studies to establish their credibility internationally.” Each of the stent needs to be proven, “says Dr. Ashok Seth, Cardiologist for Fortis- the group at the hospital. He added that the study showed that there was no difference between biodegradable polymer coating stents and permanent polymer coating added to the argument that biodegradable polymer-coated stents would get a higher price.

Rather cheaper, but not everyone benefits

Before the price tag, the cost was unavoidable for more than two stents, and so people often chose open heart when it turned out to be cheaper than angioplasty. But now multi-stenting is affordable and many patients who would have had to go for open heart surgery now choose stenting.

Dr Upendra Kaul, president of Batra Heart Center, who initiated the previous year study compared Supra Flex to Xience together with Prof. Patrick Serruys from the Netherlands, pointed out that even with good new generation stents 3% of patients still had heart attacks and needed restenosis every year. “Further research is being done to reduce this 3%,” says Dr. Kaul.

Yukon stents are made in India from German technology, while Supra Flex is a completely domestic stent, Dr. Kaul pointed out. In an editorial journal of the Euro Intervention magazine last year, Dr Kaul wrote: “There is an opinion in the heart of cardiologists, transferred to patients that imported stents are superior.” He added that it was time for Indian companies to prove that cardiologists and patients that their products were as safe and effective as in multinational companies.

Until now, no brand of drug-destructive stents anywhere in the world has proven to be superior to other brands in the market, as Dr. Kaul and Dr. Seth pointed out.

Published by